10.6084/m9.figshare.c.3641030_D3.v1 Ian Krop Ian Krop Shanu Modi Shanu Modi Patricia LoRusso Patricia LoRusso Mark Pegram Mark Pegram Ellie Guardino Ellie Guardino Betsy Althaus Betsy Althaus Dan Lu Dan Lu Alexander Strasak Alexander Strasak Anthony Elias Anthony Elias Additional file 3: Table S2. of Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer Springer Nature 2016 Additional pertuzumab HER 2-positive metastatic breast cancer All-grade AEs PDF 72 kb Phase 2. phase 1 b trastuzumab emtansine paclitaxel T-DM patient population 2016-03-15 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Table_S2_of_Phase_1b_2a_study_of_trastuzumab_emtansine_T-DM1_paclitaxel_and_pertuzumab_in_HER2-positive_metastatic_breast_cancer/4457531 All-grade AEs (occurring in ≥20 %) or grade ≥3 AEs (occurring in >3 %) of the total patient population in phase 1b. (PDF 72 kb)